Mechanisms of Immune Tolerance in Leukemia and Lymphoma
- Autores: Emily K. Curran, James Godfrey, Justin Kline
- Localización: Trends in immunology, ISSN 1471-4906, Vol. 38, Nº. 7, 2017, págs. 513-525
- Idioma: inglés
- Enlaces
-
Resumen
The mechanisms through which immune responses are generated against solid cancers are well characterized and knowledge of the immune evasion pathways exploited by these malignancies has grown considerably. However, for hematological cancers, which develop and disseminate quite differently than solid tumors, the pathways that regulate immune activation or tolerance are less clear. Growing evidence suggests that, while numerous immune escape pathways are shared between hematological and solid malignancies, several unique pathways are exploited by leukemia and lymphoma. Below we discuss immune evasion mechanisms in leukemia and lymphoma, highlighting key differences from solid tumors. A more complete characterization of the mechanisms of immune tolerance in hematological malignancies is critical to inform the development of future immunotherapeutic approaches.
